Premium
Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs
Author(s) -
Bernardi Massimo,
Carrabba Matteo,
Messina Carlo,
Milani Raffaella,
Sala Elisa,
Pavesi Francesca,
Gentner Bernhard,
Peccatori Jacopo,
Assanelli Andrea,
Marktel Sarah,
Corti Consuelo,
Forcina Alessandra,
Vago Luca,
Ciceri Fabio
Publication year - 2016
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.24345
Subject(s) - medicine , myeloid leukemia , karyotype , oncology , pediatrics , intensive care medicine , genetics , chromosome , biology , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom